Jeffrey M Bethony Selected Research

Jeffrey M Bethony Research Topics

Disease

37	Infections 03/2024 - 07/2006
22	Hookworm Infections (Hookworm Infection) 07/2021 - 10/2005
13	Neoplasms (Cancer) 01/2023 - 05/2011
10	Opisthorchiasis 01/2019 - 10/2009
9	Schistosomiasis (Bilharziasis) 01/2016 - 07/2006
8	Fibrosis (Cirrhosis) 01/2018 - 10/2009
8	Reinfection 12/2016 - 01/2006
6	Inflammation (Inflammations) 01/2019 - 07/2011
6	Cholangiocarcinoma 01/2018 - 01/2012
4	Persistent Infection 03/2024 - 11/2011
4	Neglected Diseases 01/2017 - 10/2010
3	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2019 - 08/2013
2	Strongyloidiasis 01/2023 - 01/2019
2	Parasitic Diseases (Parasitic Disease) 01/2020 - 06/2013
2	Digestive System Diseases 01/2019 - 01/2018
2	Bile Duct Neoplasms (Bile Duct Cancer) 01/2018 - 01/2012
2	Schistosomiasis mansoni 01/2017 - 11/2010
2	Nasopharyngeal Carcinoma 12/2014 - 01/2014
2	Hypersensitivity (Allergy) 10/2014 - 03/2014
2	Coinfection 10/2014 - 01/2013
2	Anemia 08/2008 - 01/2008
1	Pain (Aches) 03/2024
1	Fever (Fevers) 03/2024
1	Headache (Headaches) 03/2024
1	Iron Deficiencies 03/2024
1	Kaposi Sarcoma (Kaposi's Sarcoma) 12/2022
1	COVID-19 07/2022
1	Nematode Infections 01/2020
1	Trichuriasis 01/2020
1	Chikungunya Fever 01/2018
1	Arthritis (Polyarthritis) 01/2018
1	Wounds and Injuries (Trauma) 11/2015
1	Carcinogenesis 01/2014
1	Falciparum Malaria (Plasmodium falciparum Malaria) 08/2013
1	Glomerulonephritis 01/2013
1	Disease Progression 10/2012
1	Urticaria (Hives) 07/2012

Drug/Important Bio-Agent (IBA)

24	VaccinesIBA 03/2024 - 10/2005
15	AntigensIBA 03/2024 - 07/2006
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2008
10	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2012
7	Immunoglobulin G (IgG)IBA 01/2023 - 11/2008
5	AntibodiesIBA 01/2020 - 09/2009
5	Interleukin-6 (Interleukin 6)IBA 11/2015 - 10/2009
5	MicroRNAs (MicroRNA)IBA 12/2014 - 01/2014
4	EnzymesIBA 01/2023 - 08/2013
4	Formaldehyde (Formol)FDA Link 12/2022 - 03/2012
4	Praziquantel (Biltricide)FDA Link 01/2019 - 01/2015
4	Immunoglobulin E (IgE)IBA 10/2014 - 07/2012
4	CytokinesIBA 06/2013 - 11/2008
3	ImmunosorbentsIBA 01/2023 - 01/2015
3	8-Hydroxy-2'-DeoxyguanosineIBA 01/2019 - 01/2015
3	CarcinogensIBA 01/2015 - 07/2011
2	Viral ProteinsIBA 12/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 01/2020
2	AnthelminticsIBA 12/2016 - 09/2011
2	Subunit VaccinesIBA 01/2016 - 03/2014
2	ethyl acetateIBA 01/2015 - 03/2012
2	Immunoglobulins (Immunoglobulin)IBA 01/2015 - 08/2013
2	AllergensIBA 10/2014 - 01/2013
2	ChemokinesIBA 06/2013 - 11/2008
2	TetraspaninsIBA 01/2012 - 07/2006
2	Neutralizing AntibodiesIBA 05/2010 - 09/2009
1	Circulating Tumor DNAIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	Human Immunodeficiency Virus nef Gene ProductsIBA 12/2022
1	nef Gene Products (nef Gene Product)IBA 12/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 07/2022
1	mRNA VaccinesIBA 07/2022
1	Immunoglobulin Variable RegionIBA 01/2019
1	Cytidine DeaminaseIBA 01/2019
1	CurcuminIBA 01/2018
1	Immunomodulating AgentsIBA 01/2018
1	Viral RNAIBA 01/2018
1	Aluminum Hydroxide (Algeldrate)FDA Link 01/2017
1	ProteomeIBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 01/2015
1	Monoclonal AntibodiesIBA 01/2015
1	benzimidazoleIBA 01/2015
1	Trichloroacetic AcidIBA 01/2015
1	ParaffinIBA 12/2014
1	Histidine (L-Histidine)FDA Link 08/2013
1	Merozoite Surface Protein 1 (MSA1)IBA 08/2013
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 08/2013
1	Interleukin-10 (Interleukin 10)IBA 06/2013
1	human oval cell antigenIBA 01/2013
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2013
1	Virulence Factors (Pathogenicity Factors)IBA 12/2012
1	Interleukin-23 (Interleukin 23)IBA 02/2012
1	Interleukin-22 (IL-22)IBA 02/2012
1	ThioredoxinsIBA 01/2012
1	aluminum sulfate (alum)IBA 01/2012
1	A 19IBA 01/2012
1	InterleukinsIBA 01/2012

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2019 - 01/2006
5	Mass Drug Administration 04/2016 - 06/2008
2	Therapeutics 12/2022 - 02/2012
1	Art Therapy 12/2022
1	Chemoprevention 01/2018